Figure. Percentage of providers who state that the US Preventive Services Task Force draft recommendations will change their prostate-specific antigen (PSA) screening practice according to how strongly they agree or disagree with the draft recommendations. The sample included providers who had previously heard of the draft recommendations (N = 114).
Pollack CE, Noronha G, Green GE, Bhavsar NA, Carter HB. Primary Care Providers' Response to the US Preventive Services Task Force Draft Recommendations on Screening for Prostate Cancer. Arch Intern Med. 2012;172(8):668-670. doi:10.1001/archinternmed.2012.135
Author Affiliations: Division of General Internal Medicine (Drs Pollack and Bhavsar), Department of Pediatrics (Dr Bhavsar), and The James Buchanan Brady Urological Institute (Dr Carter), Johns Hopkins University School of Medicine, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health (Drs Pollack and Bhavsar), and Johns Hopkins Community Physicians (Drs Noronha and Green), Baltimore, Maryland.